Westport Innovations Rallies on Acquisition Chatter and 3 Stock Analyses Making Rounds

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Current Price: $57.18

William Blair has increased the company’s price target due to increased confidence in BMN-701 after the Lysosomal Disease Network WORLD Symposium. The firm still names BioMarin as a top pick for 2013 and reiterates its Outperform rating on stock.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business